Formulation and Evaluation of a Self-Emulsifying Emulsion as an Effective Adjuvant for Inactivated Foot-and-Mouth Disease Vaccine in Mice
Pharmaceutics · 10.11.2026 · 18 (11) · 1458
DOI: 10.3390/pharmaceutics18111458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 10.11.2026. Verfasst von Zhenglei Wang und 12 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key R&D Program of China, Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu Province of China.
Abstract (Originalsprache)
Background/Objectives: Foot-and-mouth disease (FMD) is an acute and febrile infectious disease that spreads rapidly among cloven-hoofed animals. Vaccination is one of the most effective methods for controlling FMD. However, commercially available FMD vaccines often have limitations in terms of stability, safety, and efficacy.
Methods
In this study, a novel self-emulsifying oil-in-water (O/W) emulsion (SEEX2-17) was developed, characterized, and evaluated as an adjuvant against the inactivated FMD vaccine in mice.
Results
The data revealed that SEEX2-17 was a homogeneous nanoemulsion with a small particle size (~25 nm) and excellent stability (for at least 2 months at 37 °C). Toxicity evaluation of SEEX2-17 showed that it had good safety and tolerability in mice. Moreover, the SEEX2-17-adjuvanted inactivated FMD vaccine induced significantly higher titers of FMDV-specific IgG antibodies when administered to mice subcutaneously and prolonged the duration of high-titer antibodies compared with the commercial ISA206-adjuvanted vaccine or antigen alone, respectively, within 12 weeks after immunization (p < 0.05). Furthermore, the vaccine adjuvanted with SEEX2-17 elicited significantly higher levels of IgG1 and IgG2a antibodies, as well as higher concentrations of cytokines (IFN-γ, IL-2, IL-4, and IL-6) than the antigen alone, indicating that the SEEX2-17-adjuvanted vaccine stimulated vigorous humoral and cellular immunity in mice. Moreover, SEEX2-17 promoted the maturation and activation of dendritic cells (DCs) in the lymph nodes as well as the proliferation of lymphocytes in the spleen.
Conclusions
Collectively, SEEX2-17 could trigger enhanced immunity and provide a promising and easy-to-use adjuvant platform for inactivated FMD vaccines with favorable stability and safety.
Förderung
- the National Key R&D Program of China
- Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu Province of China
Zitieren
APA
Wang, Z., Xuan, D., Sun, N., Li, Z., Tang, J., Zhao, Y., Wang, H., Yin, H., Bao, Y., Huang, C., Zhang, J., Xu, Y., & Miao, J. (2026). Formulation and Evaluation of a Self-Emulsifying Emulsion as an Effective Adjuvant for Inactivated Foot-and-Mouth Disease Vaccine in Mice. Pharmaceutics, 18(11), 1458. https://doi.org/10.3390/pharmaceutics18111458
Vancouver
Wang Z, Xuan D, Sun N, Li Z, Tang J, Zhao Y, et al. Formulation and Evaluation of a Self-Emulsifying Emulsion as an Effective Adjuvant for Inactivated Foot-and-Mouth Disease Vaccine in Mice. Pharmaceutics. 2026;18(11):1458. doi:10.3390/pharmaceutics18111458
BibTeX
@article{Wang2026,
author = {Wang, Zhenglei and Xuan, Dechun and Sun, Naiyan and Li, Zhi and Tang, Jianzhong and Zhao, Yanyan and Wang, Haidong and Yin, Huifang and Bao, Yinli and Huang, Cuiqin and Zhang, Jinqiu and Xu, Yuanyuan and Miao, Jinfeng},
title = {Formulation and Evaluation of a Self-Emulsifying Emulsion as an Effective Adjuvant for Inactivated Foot-and-Mouth Disease Vaccine in Mice},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {11},
pages = {1458},
doi = {10.3390/pharmaceutics18111458}
}
EUVIMED